4,5-Dihydroxy-1,3-dimethylimidazolidin-2-one

CAS : 3923-79-3

Ref. 3D-FD178352

Informations sur le produit

• Nom: 4,5-Dihydroxy-1,3-dimethylimidazolidin-2-one
• Synonymes: 1,3-Dimethyl-4,5-dihydroxy-2-imidazolidinone, 1,3-Dimethyl-4,5-dihydroxyethyleneurea, 2-Imidazolidinone, 4,5-dihydroxy-1,3-dimethyl-, 4,5-Dihydroxy-1,3-dimethyl-2-imidazalidinone, 4,5-Dihydroxy-1,3-dimethyl-2-imidazolidinone, 4,5-Dihydroxy-1,3-dimethyl-2-imidazolinone, 4,5-Dihydroxyethylenedimethylurea, Arkofix NZF, Dihydroxy-N,N′-dimethylethyleneurea, Dihydroxydimethylethyleneurea, Dimethyl(1,2-dihydroxyethylene)urea, Dimethyldihydroxyethyleneurea, Dimethylglyoxalmonourein, Fixapret NF, N,N′-Dimethyl-4,5-dihydroxyethyleneurea, NF 168 (monomer), Nf 168, Nsc 57547, 4,5-Dihydroxy-1,3-dimethylimidazolidin-2-one

Description

4,5-Dihydroxy-1,3-dimethylimidazolidin-2-one (4,5-DHDMI) is a drug that can be used to treat nitrite poisoning. It is an electron donor for the reduction of nitrite in vivo. 4,5-DHDMI has been shown to bind to magnesium ions and act as a binder for the treatment of fungal infections. In addition, 4,5-DHDMI can be used as an alternative treatment for osteoporosis. This drug has also been shown to inhibit the growth of bacteria by binding to hypophosphite in the bacterial cell wall and preventing the formation of phosphotriester bonds with ATP.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 146.14 g/mol
• Formule: C₅H₁₀N₂O₃
• Degré de pureté: Min. 95%